Standard Biotools (LAB) Enterprise Value (2010 - 2026)
Standard Biotools (LAB) posted quarterly Enterprise Value of -$455.2 million for Q1 2026, down 74.63% year-over-year from -$1.8 billion in Q1 2025, and down 142.66% quarter-over-quarter from -$187.6 million in Q4 2025.
Standard Biotools (LAB) Enterprise Value (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Enterprise Value for 17 consecutive years, with -$455.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 74.63% year-over-year to -$455.2 million; the TTM figure through Mar 2026 stood at -$455.2 million (down 74.63% YoY), while the FY2025 annual figure was -$187.6 million, up 36.41% from the prior year.
- Enterprise Value declined to -$455.2 million in Q1 2026 per LAB's latest filing, from -$187.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$31.0 million in Q1 2022 and bottomed at -$463.6 million in Q1 2024.
- Historically, Enterprise Value has averaged -$235.1 million across 5 years, with a median of -$194.9 million in 2025.
- Annual changes were most pronounced in 2022 — Enterprise Value slumped 20788.48% — and 2025, when it soared 46.98%.
- Standard Biotools' Enterprise Value stood at -$166.8 million in 2022, then jumped by 30.64% to -$115.7 million in 2023, then plunged by 154.96% to -$295.0 million in 2024, then surged by 36.41% to -$187.6 million in 2025, then tumbled by 142.66% to -$455.2 million in 2026.
- Business Quant data shows LAB's Enterprise Value at -$455.2 million in Q1 2026, -$187.6 million in Q4 2025, and -$194.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | -4.95 Bn |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | -3.48 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | -297.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | -4.15 Bn |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | -1.95 Bn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | -1.88 Bn |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | -3.29 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -467.80 Mn |
| 10 | Standard Biotools | 253.41 Mn | -223.31 Mn | 10.54 Mn | -476.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -476.72 Mn |
| Mar 31, 2026 | -455.18 Mn |
| Dec 31, 2025 | -187.58 Mn |
| Sep 30, 2025 | -194.90 Mn |
| Jun 30, 2025 | -237.09 Mn |
| Mar 31, 2025 | -260.65 Mn |
| Dec 31, 2024 | -294.96 Mn |
| Sep 30, 2024 | -367.62 Mn |
| Jun 30, 2024 | -396.00 Mn |
| Mar 31, 2024 | -463.57 Mn |
| Dec 31, 2023 | -115.69 Mn |
| Sep 30, 2023 | -129.65 Mn |
| Jun 30, 2023 | -143.10 Mn |
| Mar 31, 2023 | -155.33 Mn |
| Dec 31, 2022 | -166.80 Mn |
| Sep 30, 2022 | -186.18 Mn |
| Jun 30, 2022 | -212.23 Mn |
| Mar 31, 2022 | -31.00 Mn |
| Dec 31, 2021 | -29.47 Mn |
| Sep 30, 2021 | -30.33 Mn |